Or just partnering for OL like we are doing with Merck and AE37, except let the partner pay for most of the trial, and they would get a percentage of the spinoff for that. Not necessarliy just us licensing it.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
